FOXA1 and posterior cortical atrophy: Moreover, mutations altering pathways involved in prostate carcinogenesis including FOXA1‐, SPOP‐ and ATM‐regulated signals could be useful to discover new therapeutic targets for the treatment of metastatic PCa.